Rentschler Biopharma

Rentschler Biopharma is a premier contract development and manufacturing organization (CDMO) specializing in client projects. Rentschler Biopharma provides process development and manufacture of biopharmaceuticals, as well as related consultancy operations such as project management and regulatory support, from its headquarters in Laupheim, Germany, and its plant in Milford, MA, USA. Rentschler Biopharma's high quality is demonstrated by its extensive expertise and excellence as a client solution partner.

A high-level quality management system, a well-established operational excellence culture, and cutting-edge technology ensure product quality and productivity at every stage of development and production. Rentschler Biopharma has formed a strategic agreement with Leukocare AG in order to provide best-in-class formulation development across the biopharmaceutical value chain. The company's structure ensures quick decision-making as well as effective and smooth-running procedures in order to meet project deadlines. Rentschler Biopharma established a reputation as a biotechnology pioneer through the early development of various interferon medicines.

Rentschler Biopharma contributes significantly to biopharmaceutical production, thereby satisfying the demands of developing therapeutics and assisting millions of patients on a daily basis. It is among the finest in the market and has established new benchmarks in client focus, specific personalized solutions, and dependability. It has quickly established itself as an international CDMO in its field. Its performance in the present and future is driven by its conviction.

Founded: 1927
Headquarters: Laupheim, Germany
Website: https://www.rentschler-biopharma.com/